Walgreens Boots Alliance Aktie
WKN DE: A12HJF / ISIN: US9314271084
18.10.2023 12:15:41
|
Walgreens, CRF Collaborate To Advance PREVUE-VALVE Study - Quick Facts
(RTTNews) - Walgreens said the company is collaborating with the Cardiovascular Research Foundation to advance the PREVUE-VALVE clinical trial for valvular heart disease treatments. Walgreens will provide patient recruitment services to support the PREVUE-VALVE study, which seeks to define the prevalence of valvular heart disease in older Americans and to ensure representative access and enrollment. The PREVUE-VALVE study is currently underway, with topline results anticipated in 2025.
Walgreens noted that, in a similar Phase 3 cardiovascular study, the company exceeded its recruitment within weeks.
For More Such Health News, visit rttnews.com.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Walgreens Boots Alliance Incmehr Nachrichten
Analysen zu Walgreens Boots Alliance Incmehr Analysen
04.01.24 | Walgreens Boots Alliance Neutral | UBS AG |
Aktien in diesem Artikel
Walgreens Boots Alliance Inc | 9,70 | 0,86% |
|